Xenon Pharmaceuticals Inc.
Pharmaceutical Preparations
200 - 3650 Gilmore Way, Burnaby, A1, V5g 48w Insider Ownership
Above 5% Ownership
- SC 13G/A
- SC 13G/A
- 4
- SC 13G/A
- SC 13G/A
- 497
- N-CSR
- 485APOS
- N-CSR
- NSAR-A
- 13F-HR/A
- SC 13G/A
- SC 13G
- SC 13G/A
- 13F-HR
- SC 13G/A
- SC 13G
- SC 13G/A
- SC 13G
- SC 13G/A
- 4
- 4
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G/A
- 13F-HR
- SC 13G
- CORRESP
- DFAN14A
- SC 13G/A
- SC 13G/A
- SC 13G
- 13F-HR
- SC 13G
- 4
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G
- 4
Aulin Sherry
Aulin Sherry
12 Mar 24
Aulin Sherry
14 Mar 23
Aulin Sherry
07 Sep 22
Aulin Sherry
03 Jun 21
Aulin Sherry
03 Jun 21
Aycardi-fonseca Ernesto
Aycardi-fonseca Ernesto
13 Mar 20
Aycardi-fonseca Ernesto
18 Sep 19
Aycardi-fonseca Ernesto
20 Mar 18
Aycardi-fonseca Ernesto
20 Mar 18
Azab Mohammad
Azab Mohammad
02 Jun 23
Azab Mohammad
06 May 15
Azab Mohammad
12 Jan 15
Azab Mohammad
23 Jul 09
Azab Mohammad
29 Nov 04
Bridger Gary
Bridger Gary
11 Jun 24
Bridger Gary
11 Jun 20
Bridger Gary
02 Apr 19
Bridger Gary
03 Nov 15
Bridger Gary
07 May 14
Cohen Charles J.
Cohen Charles J.
13 Dec 18
Cohen Charles J.
13 Mar 18
Cohen Charles J.
24 Oct 17
Cohen Charles J.
21 Dec 15
Cohen Charles J.
19 Mar 15
Corraini Karen G.
Corraini Karen G.
19 Mar 15
Corraini Karen G.
04 Nov 14
Desjardins Clarissa
Desjardins Clarissa
15 May 23
Desjardins Clarissa
13 May 22
Desjardins Clarissa
02 Jun 20
Desjardins Clarissa
14 Jan 20
Desjardins Clarissa
14 Jan 20
Difabio Andrea
Difabio Andrea
14 Mar 23
Difabio Andrea
09 Nov 22
Difabio Andrea
03 Nov 17
Difabio Andrea
27 Mar 17
Difabio Andrea
16 Feb 17
Empfield James R.
Empfield James R.
12 Mar 24
Empfield James R.
14 Mar 23
Empfield James R.
13 Mar 18
Empfield James R.
24 Oct 17
Empfield James R.
09 Feb 16
Evans Johnston L
Evans Johnston L
06 May 15
Evans Johnston L
04 Nov 14
Evans Johnston L
05 Apr 13
Evans Johnston L
31 Jul 12
Evans Johnston L
25 Jul 12
Goldberg Y. Paul
Goldberg Y. Paul
24 Oct 17
Goldberg Y. Paul
11 Mar 16
Goldberg Y. Paul
21 Dec 15
Goldberg Y. Paul
24 Sep 15
Goldberg Y. Paul
04 Nov 14
Hayden Michael R
Hayden Michael R
03 Jun 21
Hayden Michael R
20 May 21
Hayden Michael R
14 Jul 20
Hayden Michael R
07 Apr 20
Hayden Michael R
12 Nov 14
Holler Frank A
Holler Frank A
20 Sep 19
Holler Frank A
16 Mar 18
Holler Frank A
02 Jun 17
Holler Frank A
03 Jun 16
Holler Frank A
12 Nov 14
Kenney Christopher John
Kenney Christopher John
12 Mar 24
Kenney Christopher John
24 Mar 23
Kenney Christopher John
14 Mar 23
Kenney Christopher John
21 Jan 22
Kenney Christopher John
25 Aug 21
Machado Patrick
Machado Patrick
02 Aug 19
Machado Patrick
23 May 19
Machado Clarence Patrick
30 Dec 15
Machado Clarence Patrick
23 Jun 14
Machado Clarence Patrick
01 Nov 06
Mortimer Ian
Mortimer Ian
12 Mar 24
Mortimer Ian
15 Mar 21
Mortimer Ian
13 Mar 20
Mortimer Ian
14 Mar 17
Mortimer Ian
11 Mar 16
Robin Sherrington
Robin Sherrington
08 Mar 24
Robin Sherrington
07 Mar 24
Robin Sherrington
02 Jan 24
Robin Sherrington
13 Mar 20
Robin Sherrington
19 Mar 15
Scheller Richard H
Scheller Richard H
27 Jun 19
Scheller Richard H
24 Oct 07
Scheller Richard H
22 Jan 07
Scheller Richard H
23 Nov 04
Scheller Richard H
09 Mar 04
Stein Evan A.
Stein Evan A.
31 Jan 19
Stein Evan A.
01 Apr 16
Stein Evan A.
04 May 15
Stein Evan A.
06 Nov 14
Stein Evan A.
04 Nov 14
Svoronos Dawn
Svoronos Dawn
20 Jun 24
Svoronos Dawn
06 Oct 22
Svoronos Dawn
08 Jan 21
Svoronos Dawn
21 Dec 18
Svoronos Dawn
16 Mar 16
Tarnow Michael M
Tarnow Michael M
26 Dec 18
Tarnow Michael M
05 Jun 18
Tarnow Michael M
03 Jun 16
Tarnow Michael M
06 Jun 08
Tarnow Michael M
19 Jun 06
Von Seggern Christopher
Von Seggern Christopher
14 Mar 23
Von Seggern Christopher
14 Mar 22
Von Seggern Christopher
07 Dec 21
Von Seggern Christopher
17 Aug 20
Von Seggern Christopher
17 Aug 20
Winquist Raymond
Winquist Raymond
21 Aug 17
Winquist Raymond
14 Mar 17
Winquist Raymond
04 Apr 16
Winquist Raymond
04 Apr 16
Biotechnology Value Fund L P
14 Feb 19
14 Feb 19
Bvf Partners L P/il
29 Jul 03
20 Aug 02
15 Jun 01
Smallcap World Fund Inc
Definitive Materials Filed Under The Investment Company Act Of 1940.
30 Apr 21
30 Nov 15
Post-effective Amendment Filed After Initial Registration Of A Form N-1a For Mutual Funds.
18 Sep 09
09 Jun 04
28 May 97
Point72 Asset Management, L.p.
Quarterly Holdings Report
16 Sep 24
14 Feb 24
26 Nov 19
Amended Statement Of Beneficial Ownership Of More Than 5%.
14 Feb 17
Quarterly Holdings Report
2024 undefined
Stein Evan A.
Stein Evan A.
31 Jan 19
Stein Evan A.
01 Apr 16
Stein Evan A.
04 May 15
Stein Evan A.
06 Nov 14
Stein Evan A.
04 Nov 14
Fmr Llc
09 Feb 22
14 Feb 14
16 Feb 10
10 Nov 03
11 Feb 97
Teva Pharmaceutical Industries Ltd
Conway Vikki L
05 Mar 24
Fridriksdottir Hafrun
06 Mar 18
Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.
06 Jun 17
06 May 09
27 Nov 02
Neurocrine Biosciences Inc
Bozigian Haig P.
05 Feb 15
Bvf Partners L P/il
07 Jul 08
09 Feb 07
Saunders John
23 May 03
Amendment To The S-1 Registration Statement.
22 May 96
Vivo Opportunity, Llc
Vivo Opportunity, Llc
29 Aug 24
Vivo Opportunity, Llc
08 Sep 22
Amended Statement Of Beneficial Ownership Of More Than 5%.
11 Feb 22
Amended Statement Of Beneficial Ownership Of More Than 5%.
14 Feb 19
Amended Statement Of Beneficial Ownership Of More Than 5%.
14 Feb 19
Orbimed Capital Gp Vi Llc
Orbimed Advisors Llc
15 Dec 23
Orbimed Advisors Llc
14 Dec 23
Orbimed Advisors Llc
10 Aug 22
Orbimed Advisors Llc
06 Feb 18
Orbimed Advisors Llc
26 Jul 17
Capital World Investors
11 Feb 22
Amended Statement Of Beneficial Ownership Of More Than 5%.
11 Feb 22
Amended Statement Of Beneficial Ownership Of More Than 5%.
11 Feb 22
Amended Statement Of Beneficial Ownership Of More Than 5%.
14 Feb 20
Amended Statement Of Beneficial Ownership Of More Than 5%.
14 Feb 20
Orbimed Advisors Llc
Orbimed Advisors Llc
13 May 22
Orbimed Advisors Llc
17 Dec 21
10 Feb 09
27 Feb 07
Orbimed Advisors Llc
16 Aug 05
Avoro Capital Advisors Llc
14 Nov 24
Quarterly Holdings Report
16 Feb 21
12 Feb 21
Correspondence With The Sec.
17 Feb 17
Definitive Information Statement By Non-management.
07 Feb 17
Driehaus Capital Management Llc
10 Feb 23
10 Nov 22
12 Feb 20
Quarterly Holdings Report
15 May 19
12 Feb 99
Troendle August J.
August J. Troendle
29 Apr 24
Amended Statement Of Beneficial Ownership Of More Than 5%.
06 Jul 22
Troendle August J.
21 Apr 21
Troendle August J.
17 Aug 16
Troendle August J.
16 Jun 15
Interwest Partners Vii L P
Interwest Partners Vii L P
18 Apr 08
14 Feb 07
14 Feb 07
14 Feb 06
14 Feb 06
Adage Capital Partners Gp, L.l.c.
07 Feb 24
07 Feb 24
Amended Statement Of Beneficial Ownership Of More Than 5%.
09 Feb 23
08 Jan 10
Adage Capital Partners Gp Llc
26 Feb 04